Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry
Tolga Aksu,Roderick Tung,Tom De Potter,Timothy M. Markman,Pasquale Santangeli,Jeanne du Fay de Lavallaz,Jeffrey R. Winterfield,Tina Baykaner,Daniel Alyesh,Jacqueline E. Joza,Rakesh Gopinathannair,Patrick Badertscher,Duc H. Do,Ayman Hussein,Jose Osorio,Thomas Dewland,Alexander Perino,Albert J. Rodgers,Christopher DeSimone,Alberto Alfie,Brett D. Atwater,David Singh,Kapil Kumar,Jonathan Salcedo,Jason S. Bradfield,Gaurav Upadhyay,Nitesh Sood,Parikshit S. Sharma,Sandeep Gautam,Vineet Kumar,Alexander Romeno Janner Dal Forno,Christopher E. Woods,Moshe Rav-Acha,Chiara Valeriano,Sunil Kapur,Andres Enriquez,Sri Sundaram,Michael Glikson,Edward Gerstenfeld,Jonathan Piccini,Wendy S. Tzou,William Sauer,Andre d’Avila,Kalyanam Shivkumar,Henry D. Huang
DOI: https://doi.org/10.1007/s10840-024-01789-9
2024-03-20
Journal of Interventional Cardiac Electrophysiology
Abstract:Cardioneuroablation has been emerging as a potential treatment alternative in appropriately selected patients with cardioinhibitory vasovagal syncope (VVS) and functional AV block (AVB). However the majority of available evidence has been derived from retrospective cohort studies performed by experienced operators.
cardiac & cardiovascular systems